Researchers introduce ten-minute breath test to monitor antibiotic concentrations

Exhaled breath may be very promising alternative to blood for the therapeutic monitoring of antibiotics, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.

Powered by WPeMatico

Haryana NEET Aspirant found dead in Kota, parents suspect murder, Probe On

Kota: In a tragic incident, yet another student preparing for NEET in Kota has been found dead hanging from the ceiling fan of his hostel room. According to the police, the aspirant’s parents suspect that he was murdered.

Speaking to PTI, the police officials informed, “A 20-year-old NEET aspirant was found hanging from the ceiling fan of his hostel room in Kunhari area here, with his parents suspecting he was murdered, police said on Monday.”

This is the eighth case of suspected suicide by a coaching student in Kota since January. The number of student suicides in Kota stood at 26 in 2023.

The aspirant, who hailed from Haryana’s Rohtak, had been preparing for NEET at a coaching institute here for over a year, the police said. His parents have demanded the registration of a murder case against unidentified persons and an impartial investigation into the matter.

Also Read:UP student preparing for NEET in Kota Missing, police yet to trace

On demand of the student’s parents, a medical board was constituted to perform the autopsy, said Assistant Sub-Inspector Kaptan, who is investigating the case. The body was handed over to the family after the post-mortem, they said.

The student had allegedly hanged himself around 9 hours before his body was spotted by the hostel staff, the ASI said.

Panchal’s body was found hanging from the ceiling fan of his room at the hostel in Landmark City under the Kunhari police station limits on Sunday night, they said.

However, his parents suspected Panchal was murdered, citing that the injury on his neck from the rope was too deep to be caused by hanging, the police said.

A case of unnatural death under section 174 of the Criminal Procedure Code has been lodged for initial investigation in the matter, they said.

No suicide note was recovered from the student’s hostel room and the reason behind his extreme step is yet to be ascertained, Arvind Bhardwaj, Circle Inspector (CI) at Kunhari police station, said on Monday.

Panchal was supposed to take the NEET-UG exam next month, the police said.

He allegedly hanged himself sometime on Sunday noon but the matter came to light only around 9.30 pm when the warden spotted the body and informed the police, the CI said.

A police team rushed to the spot and recovered the body and shifted it to the mortuary of MBS Hospital for postmortem, he added.

In gross violation of safety norms, the hostel room did not have an anti-suicide device installed with the ceiling fan, which could have averted the tragedy, the officer added.

Meanwhile, the deceased’s father, uncle and grandfather who reached Kota on Monday morning to claim the body suspected foul play and claimed Panchal did not commit suicide but was murdered.

“***was good at studies and would always assure us of securing a rank among the top ten. He cannot commit suicide,” his uncle Surendra Panchal told PTI outside the mortuary.

The wound on his neck is so deep that it couldn’t have been caused by hanging, he claimed and demanded autopsy by medical board.

The student’s family has also demanded the formation of a SIT for investigation in the matter, CI Bhardwaj further informed PTI.

Powered by WPeMatico

Why is India witnessing a rise in Uterus Cancer in Older Women? – Dr Prathima Reddy

Uterine cancer, primarily affecting postmenopausal women, has seen a concerning uptick in incidence rates in recent times. This surge in cases is predominantly noted in urban regions, surpassing the rates of cervical cancer in these areas.

There’s been a 132% increase in the number of Uterine cancer cases worldwide. Uterine cancer, also known as endometrial cancer, originates in the lining of the womb (endometrium). It is the most common gynecologic cancer worldwide, and the incidence in India is about 3.9%. says Dr Prathima Reddy, Director & Lead Consultant, Department of Obstetrics and Gynaecology, SPARSH Hospital, Bangalore.

Causes

A few causes why women in urban areas are more affected by Uterine Cancer:

1) Obesity: Easy access to high-calorie foods and decreased physical activity compared to rural areas increases the chances of obesity among people living in Urban areas. Obesity, in turn, constitutes a risk factor for uterine cancer.

2) Sedentary Lifestyle and Dietary Factors: Urban lifestyles, characterized by sedentary behaviours like prolonged sitting due to desk jobs or car commuting, coupled with diets high in processed foods and sugars, increase the risk of uterine cancer. In contrast, rural lifestyles often entail more physical activity and diets rich in fresh fruits, vegetables, and whole grains, which are linked to a decreased risk of uterine cancer.

3) Reproductive Factors: Never having had children increases the risk of uterine cancer as opposed to having at least one pregnancy. Career priorities in urban women may contribute to this.

4) Environmental Factors: Urban areas may have higher levels of pollution, exposure to endocrine-disrupting chemicals, and other environmental factors that could contribute to the development of uterine cancer.

5) Hormonal Factors: Exposure to hormones, whether through hormone replacement therapy or other medications, may differ between urban and rural populations due to differences in healthcare access and prescribing patterns. Hormonal influences play a significant role in the development of uterine cancer among women.

The increasing occurrence of uterine cancer poses a notable public health concern demanding immediate attention and collaborative effort. By understanding the underlying factors driving this trend, we can strive to reverse the trajectory and reduce the burden of uterine cancer on women’s health and well-being.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Powered by WPeMatico

Restrict mobile phone use On Duty, No jewellery below elbow: DGHS Advisory for healthcare workers

New Delhi: To safeguard the well-being of both patients and healthcare personnel, the Director General of Health Sciences (DGHS) has directed all the healthcare workers of Central government hospitals not to wear jewellery below the elbow and restrict the use of mobile phones while on duty in critical areas.

Issuing a directive in this regard, Dr Atul Goel, Director General of Health Sciences asked respective hospitals to maintain hygiene to minimize the risk of infection transmission and to ensure that an optimum standard of hygiene and patient care are maintained at all times.

Dr Atul Goel has directed all the directors and medical superintendents of central government hospitals to introduce certain safety protocols to reinforce infection control practices within their facilities. 

Jewellery below the elbow and usage of mobile phones while on duty have been prohibited to prevent the potential spread of infection and minimize infection risks.

Also read- Attention Doctors: Now, You Have To Mention Exact Indication, Reason, Justification While Prescribing Antibiotics

Addressing the director or medical superintendents of central government hospitals, Dr Atul said, “There is substantial evidence that wearing hand jewellery below the elbow increases total skin microorganism counts. Similarly, the use of mobile phones, while on duty especially in critical areas like ICUS, HDUS, post-operative wards and OTS, poses infection risks.”

“Effective immediately, all healthcare workers of Central Govt. Hospitals are required to remove all types of jewellery below the elbow while on duty. This includes rings, bangles, bracelets, religious threads and wristwatches. This precaution is essential to minimize the risk of infection transmission and to ensure that an optimum standard of hygiene and patient care are maintained at all times. Respective hospitals can revise their SOPS on hand hygiene and specifically mention where wristwatches are permitted,” said the order.

In addition, it has been directed to create and implement a policy that limits the usage of cell phones in patient zones and high-risk areas like ICUs, HDUs, post-operative wards, and operation rooms.

“We understand that this may require some adjustments, but we trust that you will prioritize the safety and welfare of our patients above all else. Your cooperation in this matter is greatly appreciated and will contribute to creating a safer and more conducive healing environment for all,” added the order.

Also read- Union Health Minister Inaugurate New Health Facilities In Central Government Hospitals

Powered by WPeMatico

Bird Flu Outbreak in Jharkhand: 2 doctors, 4 farm staff test negative for virus

Ranchi: Amidst an outbreak of bird flu in Ranchi, two doctors and four staff members from the Regional Poultry Farm in Hotwar tested negative for the infection, the officials said. 

Two doctors and six staff members of the Regional Poultry Farm in Hotwar were quarantined for two days at the JSIA building in Ranchi.

According to officials, the JSIA government building has been turned into a bird flu ward. A team of medical experts from Ranchi have taken the samples of infected people, news agency ANI reported.

Almost all cases of H5N1 infection in people have been associated with close contact with infected live or dead birds or H5N1-contaminated environments.

Also Read:H5N1 bird flu strain found in raw milk from infected animals: WHO

Their test results have returned negative,” Dr Kamlesh Kumar Pingley, the assistant director of the regional poultry farm in Hotwar, told TOI.

A series of actions including a total restriction on the sale and purchase of all birds and conducting surveys around the epicentre have been taken under the Ministry of Animal Husbandry following the confirmation of the bird flu outbreak.

Ranchi Deputy Commissioner Rahul Kumar Sinha told ANI, “Bird Flu has been confirmed in Ranchi. As soon as bird flu was confirmed, a series of actions take place under the guidelines mentioned in the Ministry of Animal Husbandry. The first action is a total ban on the sale and purchase of all birds in one kilometre radius of the epicentre.”

Further, the official said, “A survey of all the birds is also conducted in the region. A machinery of the district has also been deployed for the containment of the bird flu. The District Animal Husbandry Office, Municipal Corporation, Police and Magistrate have formed a rapid response team.””

In this context, advisories have been issued in newspapers, additionally, the administration will ensure the application of all kinds of precautionary measures in the region for containment of Bird Flu,” he said. The Animal Husbandry Directorate, Ranchi, has formed a Rapid Response Team (RRT) for the culling of poultry and cleaning and disinfection of infected areas after H5N1 Avian Influenza (Bird Flu) was detected in the poultry area, Hotwa.

The RRT team will work to disinfect the area within one kilometre of epicentre in the poultry area, Hotwa.

Meat technologist at the Regional Poultry Farm, Dr Santosh Kumar, told ANI, “In the one km radius, all chickens and eggs will be disposed of. We will tell all farmers and shopkeepers not to bring any outside poultry. Until we do not receive a negative report, we will ask them not to farm chicken.”

On the orders of the District Collector, about 1745 chickens, 450 ducks and 1697 eggs have been disposed off.

H5N1 stands for Highly Pathogenic Asian Avian Influenza (H5N1) Virus. Avian influenza is a strain of the influenza virus that primarily infects birds, but can also infect humans. This type of flu is most often contracted by contact with sick birds. It can also be passed from person to person. Almost all cases of H5N1 infection in people have been associated with close contact with infected live or dead birds or H5N1-contaminated environments.

Powered by WPeMatico

Granules India arm gets USFDA nod for Gout flares drug Colchicine

Hyderabad: Granules India Limited today announced that the US Food & Drug
Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules
Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company, for Colchicine Capsules, 0.6
mg.

It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mitigare Capsules,
0.6 mg of Hikma International Pharmaceuticals LLC.

Colchicine Capsules are indicated for prophylaxis of gout flares in adults. Gout flares refer to sudden and intense episodes of pain, swelling, redness, and warmth in the joints, typically caused by the buildup of uric acid crystals. These flares often occur in the big toe but can also affect other joints such as the ankles, knees, elbows, wrists, and fingers.

Granules now have a total of 64 ANDA approvals from the US FDA (63 Final approvals and 1 tentative
approvals).
The current annual U.S. market for Colchicine Capsules is approximately $55 Million, according to MAT Feb
2024, IQVIA/IMS Health.

Read also: Granules India bags USFDA nod for Pantoprazole Sodium Delayed Release Tablets

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. The Company is among the few pharmaceutical companies in the world to be present in the manufacturing of entire value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs). Its products are being distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, U.S. and U.K. The Company has 7 manufacturing facilities out of which 6 are located in India and 1 in USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC and HALAL.

Read also: Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension

Powered by WPeMatico

Insulin resistance linked with increased cardiovascular risk not kidney risk in diabetes patients: Study

A recent study published in the Journal of Diabetes Care investigated the association between insulin resistance, cardiorenal risk and the effectiveness of finerenone to the management of type 2 diabetes.

This FIDELITY study involved a total of 13,026 patients with type 2 diabetes and examined whether insulin resistance, measured by estimated glucose disposal rate (eGDR), influence the risk of cardiovascular and kidney complications. Furthermore, if the risk affected the effectiveness of finerenone when compared to a placebo was examined.

The results showed that patients with lower eGDR had a significantly higher incidence of cardiovascular events compared to those with higher eGDR, irrespective of treatment that indicates insulin resistance. The incidence rate of cardiovascular events per 100 patient-years for finerenone was 5.18 and for placebo was 6.34 in the lower eGDR group, versus 3.47 for finerenone and 3.76 for placebo in the higher eGDR group.

There was no significant association found between eGDR and kidney outcomes. Also, the study revealed that the efficacy of finerenone in reducing cardiovascular and kidney complications was consistent across patients with different levels of insulin resistance.

The findings underscore the importance of considering insulin resistance as a significant risk factor for cardiovascular events in patients with type 2 diabetes. While insulin resistance was not associated with kidney outcomes in this study, it remains as a crucial factor in assessing overall cardiorenal risk.

The outcomes provide valuable insights into the complex interplay between insulin resistance, cardiovascular risk and medication efficacy in individuals with type 2 diabetes. Understanding these relationships can improve more targeted treatment strategies for patients with this chronic condition.

Source:

Ebert, T., Anker, S. D., Ruilope, L. M., Fioretto, P., Fonseca, V., Umpierrez, G. E., Birkenfeld, A. L., Lawatscheck, R., Scott, C., Rohwedder, K., & Rossing, P. (2023). Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance. In Diabetes Care. American Diabetes Association. https://doi.org/10.2337/dc23-1420

Powered by WPeMatico

Blood glucose fluctuation linked to in-hospital mortality in acute MI patients, reveals study

China: A recent study published in PLOS One has uncovered a significant association between blood glucose fluctuation and in-hospital mortality among patients experiencing acute myocardial infarction (AMI). The findings of this study provide important insights into managing blood glucose levels in AMI patients, with potential implications for improving outcomes and reducing mortality rates.

The study found a correlation between glycemic variability and in-hospital mortality, particularly among AMI patients with normal blood glucose levels at admission. The findings suggest that early intervention should be implemented to normalize high blood glucose levels at admission to AMI.

Acute myocardial infarction is a fatal disease caused by acute and persistent ischemia and hypoxia of coronary arteries, leading to high morbidity and mortality rates. It is crucial to explore simple biomarkers for assessing the risk of in-hospital mortality in patients with AMI. Therefore, Nan Liang, Department of Cardiology, Xinjiang Armed Police Corps Hospital, Urumqi City, Xinjiang Province, P. R. China, and colleagues aimed to assess the relationship between glycemic variability, glucose fluctuation trajectory, and the risk of in-hospital mortality in acute myocardial infarction patients.

For this purpose, the researchers conducted a retrospective cohort study that included AMI patients from the eICU Collaborative Research Database. In-hospital mortality of AMI patients was the primary endpoint. The three main study variables were blood glucose levels at admission, glycemic variability, and glucose fluctuation trajectory.

Admission blood glucose levels were stratified into normal, intermediate, and high. Glycemic variability was assessed using the coefficient of variation (CV) and divided into four groups based on quartiles: quartile 1: CV≤10; quartile 2: 1030.

In AMI patients, the relationship between blood glucose levels at admission, glycemic variability, glucose fluctuation trajectory, and in-hospital mortality was evaluated using univariate and multivariate Cox regression models. The study included 2590 participants.

The researchers reported the following findings:

  • There was a positive relationship between high blood glucose levels at admission and in-hospital mortality [hazard ratio (HR) = 1.42].
  • The fourth quartile (CV>30) of CV was associated with increased in-hospital mortality (HR = 2.06).
  • The findings indicated that only AMI individuals in the fourth quartile of glycemic variability exhibited an elevated in-hospital mortality among those with normal blood glucose levels at admission (HR = 2.33).
  • Elevated blood glucose level was a risk factor for in-hospital mortality in AMI patients.

In conclusion, the study conducted using data from the eICU collaborative research database highlights the importance of blood glucose fluctuation as a predictor of in-hospital mortality among patients with acute myocardial infarction. The findings underscore the need for careful glycemic management in this population and suggest potential avenues for improving outcomes through targeted interventions.

Reference:

Chen, J., Huang, W., & Liang, N. (2024). Blood glucose fluctuation and in-hospital mortality among patients with acute myocardial infarction: EICU collaborative research database. PLOS ONE, 19(4), e0300323. https://doi.org/10.1371/journal.pone.0300323

Powered by WPeMatico

Lower dose of mpox vaccine safe and generates six-week antibody response equivalent to standard regimen

A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to findings presented today at the European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona. The results suggest that antibody responses contributed to the effectiveness of dose-sparing mpox vaccine regimens used during the 2022 U.S. outbreak.

The mpox virus has been present in west, central and east Africa for decades, with the first human case identified in 1970. In May 2022, a global mpox outbreak caused by the clade IIb strain of the virus provided the first epidemiologic evidence of community mpox transmission outside of historically affected countries. The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN, sold as JYNNEOS) vaccine was made available to help contain the outbreak in the United States. The National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) sponsored a study of dose-sparing strategies to extend the limited vaccine supply.

The mid-stage study enrolled 225 adults aged 18 to 50 years in the United States who had not previously been vaccinated against mpox or smallpox. Participants were randomized to receive either the standard Food and Drug Administration-approved MVA-BN regimen, a regimen containing one-fifth of the standard dose, or one with one-tenth of the standard dose. The standard dose was injected under the skin (subcutaneously), while the dose-sparing regimens were injected between layers of the skin (intradermally). Participants in all study arms received two injections 28 days apart and were monitored for safety and immune response.

Two weeks after the second dose (study day 43), participants who received one-fifth of the standard dose had antibody levels equivalent to those of participants receiving the standard MVA-BN regimen, based on predefined criteria. By day 57, participants who received one-fifth of the standard dose had lower antibody levels than those in the standard regimen arm; the clinical significance of this difference is unknown. Participants who received one-tenth of the standard dose had inferior antibody levels at all measurements. The most reported adverse events were mild, local injection-site reactions. Adverse events were similar across all arms of the trial, and no serious adverse events related to the vaccine were reported.

The authors note that because there are no defined correlates of protection against mpox-immune processes confirmed to prevent disease-these findings cannot predict the efficacy of dose-sparing regimens with certainty. Real-world data from the Centers for Disease Control and Prevention and others have shown similar vaccine effectiveness for the dose-sparing regimen given intradermally and the standard regimen given subcutaneously. A study of the standard MVA-BN regimen in adolescents is ongoing and will report findings later this year.

Reference:

Frey et al. Safety and Immunogenicity of Fractional Doses of Modified Vaccinia Ankara-Bavarian Nordic. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Barcelona, Spain. Saturday, April 27, 2024.

Powered by WPeMatico

PET/CT technique revolutionizes spinal bone metastases detection in pheochromocytoma and paraganglioma: Study

USA: Gallium-68 (Ga-68) DOTATATE PET/CT should be the modality of choice in pheochromocytoma/paraganglioma (PPGL)–-related spinal bone metastases due to its superior detection rate, a recent study published in European Radiology has shown.

The groundbreaking study has unveiled the diagnostic prowess of advanced imaging modalities in detecting spinal bone metastases associated with pheochromocytoma and paraganglioma. The research represents a significant leap forward in the early identification and management of metastatic disease in these rare neuroendocrine tumors.

“Ga-68 DOTATATE PET/CT appears to be the best approach for detecting spinal bone metastases in patients with certain neuroendocrine tumors,” the researchers stated. Bone metastases destroy and weaken skeletal tissue and predispose cancer patients to acute and chronic skeletal-related events (SREs).

In a study of patients with pheochromocytomas and paragangliomas, the group found the approach was superior to F-18 FDG-PET/CT, MRI of the spine, whole-body MRI, and whole-body CT. The finding is significant regarding efforts to prevent severe complications in these patients.

Bone metastases are frequently observed in patients with solid tumors; observed in up to 71% of metastatic PPGL patients. SREs such as spinal cord compression, bone pain, and fractures not only affect mortality and morbidity rates in these individuals but also increase medical costs. However, there is limited data from head-to-head comparisons among imaging techniques for detecting bone metastases in these patients.

To fill this knowledge gap, Karel Pacak, National Institutes of Health, Bethesda, MD, USA, and colleagues aimed to compare the diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body MRI and CT for detecting PPGL–related spinal bone metastases.

PPGL participants with spinal bone metastases prospectively underwent [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, contrast-enhanced MRI of the neck and thoracic-abdominopelvic regions (MRIWB), MRI of the cervical-thoracolumbar spine (MRIspine), and contrast-enhanced CT of the neck and thoracic-abdominopelvic regions (CTWB) between 2014 and 2020. They calculated per-lesion and per-patient detection rates.

Counting of spinal bone metastases was limited to a maximum of one lesion per vertebrae. A composite of all anatomic and functional imaging served as an imaging comparator. Detection rates between the scans were compared using the McNemar test.

The following were the key findings of the study:

· Forty-three consecutive participants (mean age, 41.7 ± 15.7 years; females, 22) with MRIspine were included who also underwent [68Ga]DOTATATE PET/CT (n = 43), [18F]FDG PET/CT (n = 43), MRIWB (n = 24), and CTWB (n = 33).

· Forty-one of 43 participants were positive for spinal bone metastases, with 382 lesions on the imaging comparator.

· [68Ga]DOTATATE PET/CT demonstrated a per-lesion detection rate of 98.7%, which was superior compared to MRIspine (80.6%), [18F]FDG (72.0%), MRIWB (55.3%), and CTWB (44.8%).

· The per-patient detection rate of [68Ga]DOTATATE PET/CT was 100%, which was higher compared to [18F]FDG PET/CT (90.2%), MRIspine (97.6%), MRIWB (95.7%), and CTWB (81.8%).

In conclusion, [68Ga]DOTATATE PET/CT demonstrated superiority in spinal bone metastase detection compared to [18F]FDG PET/CT, MRIspine, CTWB, and MRIWB indicating that it should be the imaging modality of choice when looking for metastatic spine disease associated with PPGL.

It is more sensitive than the other modalities and is also useful in the detection of primaries, soft tissue metastases, and the treatment planning and response assessment of targeted radionuclide therapy in patients with bone-only metastatic PPGL in whom response evaluation using anatomic imaging is challenging.

“Future studies may include diffusion-weighted and post-contrast images in the MRIspine protocol and determine its performance against [68Ga]DOTATATE PET/CT,” the researchers wrote.

Reference:

Jha, A., Patel, M., Ling, A. et al. Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma. Eur Radiol (2024). https://doi.org/10.1007/s00330-024-10652-4

Powered by WPeMatico